Nektar Therapeutics (NKTR) Receivables - Other: 2018-2024
Historic Receivables - Other for Nektar Therapeutics (NKTR) over the last 2 years, with Dec 2024 value amounting to $1.1 million.
- Nektar Therapeutics' Receivables - Other rose 120.00% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 120.00%. This contributed to the annual value of $1.1 million for FY2024, which is 120.00% up from last year.
- As of Q4 2024, Nektar Therapeutics' Receivables - Other stood at $1.1 million, which was up 120.00% from $500,000 recorded in Q4 2023.
- Nektar Therapeutics' 5-year Receivables - Other high stood at $6.2 million for Q1 2020, and its period low was $500,000 during Q4 2023.
- Over the past 3 years, Nektar Therapeutics' median Receivables - Other value was $700,000 (recorded in 2022), while the average stood at $766,667.
- As far as peak fluctuations go, Nektar Therapeutics' Receivables - Other plummeted by 72.55% in 2021, and later spiked by 120.00% in 2024.
- Over the past 5 years, Nektar Therapeutics' Receivables - Other (Quarterly) stood at $5.1 million in 2020, then crashed by 72.55% to $1.4 million in 2021, then slumped by 50.00% to $700,000 in 2022, then fell by 28.57% to $500,000 in 2023, then spiked by 120.00% to $1.1 million in 2024.
- Its Receivables - Other stands at $1.1 million for Q4 2024, versus $500,000 for Q4 2023 and $700,000 for Q4 2022.